Article
Applied Clinical Trials
TransCelerate Launches Three New Initiatives
TransCelerate BioPharma has launched three new initiatives. The Common Clinical Serious Adverse Events (SAE) Fields Initiative, The Modernization of Data Analytics for Clinical Development Initiative aims, and has expanded its Interpretation of Guidances and Regulations Initiative.
For more on the new initiatives, click here.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Videos
Related Content
